Recurrent Miscarriage: What UK, European and US Guidance Means for When You Should Seek Help

If you have experienced pregnancy loss more than once, one of the most confusing parts of finding help is that the professional bodies do not agree on when "recurrent" officially starts. At LivingCare, we have partnered with the fertility specialists at JIVA Fertility to make sense of the three main clinical definitions in use today and, more importantly, to help you understand when to ask for assessment, whichever number applies to you.

The Threshold Depends on Which Guideline You Read

Europe's ESHRE (European Society of Human Reproduction and Embryology) sets the lowest bar: recurrent pregnancy loss is defined as two or more losses, and they do not need to have happened one after another. Clinical evaluation can reasonably begin after a second loss under this guidance, a full pregnancy earlier than UK practice would strictly suggest.

The ASRM (American Society for Reproductive Medicine) reaches a similar number from a different direction. Its first updated committee opinion on recurrent pregnancy loss in over a decade, issued in 2026, also settles on two or more losses that do not need to be consecutive. The meaningful change is not the number, but what counts towards it: the previous 2012 position only recognised losses confirmed by ultrasound or examination of pregnancy tissue, excluding very early biochemical losses. The 2026 update now includes pregnancies confirmed by a positive blood or urine test alone, bringing ASRM much closer to UK practice on this specific point.

The UK's RCOG (Royal College of Obstetricians and Gynaecologists) sets the highest bar of the three. Its Green-top Guideline No. 17, updated in 2023, defines recurrent miscarriage as three or more first-trimester losses, and this remains the definition used in day-to-day UK clinical practice. Two details are easy to miss: the losses do not need to be consecutive, and they do not need to be with the same partner. The 2023 update removed both requirements, reflecting that conditions causing recurrent loss, such as antiphospholipid syndrome, are not affected by a change of partner. RCOG counts pregnancy from conception, so very early biochemical losses confirmed by a positive test alone are included. RCOG's guideline puts the prevalence of three or more first-trimester losses at around 0.7% of women.

Why the Numbers Differ Less Than They First Appear

None of these three bodies is wrong. They are answering slightly different clinical questions about when the balance of probability justifies investigation. And on the points that matter day to day, they now agree more than they disagree: non-consecutive losses count towards your total under all three definitions, a change of partner does not reset the count under RCOG, and RCOG's own guidance encourages clinicians to use judgement and offer targeted investigation after two losses where there is a specific reason for concern, rather than waiting rigidly for a third.

It is also worth understanding the distinction between a biochemical and a clinical pregnancy loss, since it affects how your own losses are counted. A biochemical pregnancy is confirmed only by a positive blood or urine test, before anything is visible on ultrasound. A clinical pregnancy loss is confirmed by ultrasound or, in later loss, by examination of pregnancy tissue. Whether biochemical losses count towards your total is exactly the point on which RCOG, ESHRE and the newly updated ASRM position now differ least, and where the older ASRM definition used to differ most.

Assessment Timing Should Match Your Individual Picture, Not a Fixed Rule

• After one loss: assessment is not usually needed. Emotional support and general reassurance are appropriate, and most people go on to have a successful pregnancy.
• After two losses: assessment becomes a reasonable, discretionary step, particularly if you are over 35, have been trying to conceive for a long time, or there is a specific concern such as a known uterine abnormality.
• After three losses: full assessment is recommended regardless of other factors.

If you are unsure where you sit on this scale, that uncertainty is itself a good reason to have a conversation with a healthcare professional rather than searching for a definitive number online.

What an Assessment Typically Covers

The tests used across UK and international guidance are broadly similar, and usually include:

• Antiphospholipid antibody testing, since antiphospholipid syndrome is one of the most treatable identified causes of recurrent loss.
• Parental karyotyping, where a chromosomal cause is suspected, often prompted by testing of pregnancy tissue from a third or later loss.
• Pelvic ultrasound, to check the shape of the uterus and rule out structural causes such as a uterine anomaly.
• Thyroid function tests and other relevant blood tests, including screening for diabetes where clinically indicated.

A Clear Diagnosis Is Not Required for a Good Outcome

It is worth being honest about what these tests will and will not find. In around half of cases, no clear cause is identified even after full assessment. That is not a dead end. RCOG guidance puts the chance of a successful future pregnancy at around 75% with supportive care alone, meaning early pregnancy monitoring and reassurance, even where no cause is ever found. Where a specific, treatable cause is identified, such as antiphospholipid syndrome, targeted treatment (typically low-dose aspirin and heparin) can improve that outlook further.

Common Questions Answered

What counts as a recurrent miscarriage? It depends on which guideline is used. RCOG (UK) defines it as three or more first-trimester losses. ESHRE (Europe) and the 2026-updated ASRM (US) both define it as two or more losses. All three agree the losses do not need to be consecutive.

Do the losses have to happen one after another to count? No. Under current RCOG, ESHRE and ASRM guidance, losses do not need to happen consecutively, and under RCOG they do not need to be with the same partner.

How many losses before assessment starts? Full assessment is recommended after three losses under RCOG guidance. Discretionary assessment after two losses is reasonable, particularly over the age of 35 or where there is a specific clinical concern. After one loss, assessment is not usually indicated.

What does an assessment involve? Typical tests include antiphospholipid antibody testing, pelvic ultrasound, thyroid function tests, and parental or pregnancy-tissue karyotyping where a genetic cause is suspected.

What are the chances of a successful pregnancy afterwards? Even without an identified cause, RCOG guidance puts the chance of a successful future pregnancy with supportive care alone at around 75%. Where a specific cause is found and treated, the outlook can be even better.

Getting the Right Support, at the Right Time

Understanding which definition applies to you matters less than getting a clear, individual picture of your own situation. At LivingCare, our role is to give you that early assessment and a calm, evidence-based conversation about what your history means and what the sensible next step is. If you are unsure about your own situation or how it may be affecting your fertility, speak with a LivingCare professional. We will guide you through your options and, if needed, connect you with our trusted partners at JIVA Fertility for specialised care.

Book a consultation or explore our fertility services to take the next step.

Disclaimer: This article is for informational purposes only and should not replace medical advice. Always speak to a healthcare provider about your individual health needs.

‍